glp-1 kidney protection agonists in the treatment of chronic disease in type 2 diabetes and obesity GLP-1 mediated diuresis and natriuresis
Description
Sometimes, non-event experiences were reported with no noticeable effects
March 9, 2021
You can consult with a provider who specializes in GLP-1 treatment regardless of whether they practice in your city or across the country (as long as they're licensed in your state)
doi: 10.1136/rmdopen-2024-004314
Controlled environments in animal laboratories cannot recapitulate the complexity of real-world clinical settings
